How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID).
Emily DemaPam SonnenbergJo GibbsAnne ConollyMalachi WillisJulie RiddellRaquel Bosó PérezAndrew J CopasClare TantonChris BonellClarissa OeserSoazig CliftonMagnus UnemoCatherine H MercerKirstin R MitchellNigel FieldPublished in: Sexually transmitted infections (2022)
Our study suggests differential access to key primary and secondary STI/HIV prevention interventions continued during the first year of the COVID-19 pandemic. However, there was not strong evidence that differential access has changed during the pandemic when compared with 2010-2012. While the pandemic might not have exacerbated inequalities in access to primary and secondary prevention, it is clear that large inequalities persisted, typically among those at greatest STI/HIV risk.